Wedgewood recalls compounded veterinary medicines over potency concerns

Wedgewood Pharmacy is recalling certain compounded veterinary medicines because unreliable laboratory testing data may mean products have too little or too much potency, according to the company’s announcement posted by the FDA. The recall covers products still within expiry that were shipped nationwide to veterinary practices, pharmacies and other customers between February 18, 2026 and October 6, 2026. Wedgewood has posted a list of affected products, lot numbers and expiration dates.

The products include powders, pastes, suspensions, injectables, eye and ear medicines, sprays and gels for companion, equine, exotic, zoo, wildlife and aquatic animals. They are not intended for food-producing animals. Wedgewood reported 98 complaints, of which 7 are serious. It said low potency may lead to ineffective treatment, while high potency may cause toxicity or overdose. Animal owners should stop using affected products, retain them and contact Wedgewood. Businesses should quarantine affected inventory and notify customers to whom they dispensed the products. Wedgewood is arranging refunds or replacements where possible.